What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Publication Nov 6, 2024
Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Christopher Ma, Vipul Jairath, Virginia Salitano

Publication Mar 19, 2020
ATRC Review: JAK-STAT Pathway Targeting for the Treatment of IBD

Niels Vande Casteele

Publication Jan 27, 2020
Oral Janus Kinase Inhibitors for Maintenance of Remission in Ulcerative Colitis

Vipul Jairath

Publication Oct 24, 2019
Factors Influencing Drug Disposition of Monoclonal Antibodies in Inflammatory Bowel Disease: Implications for Personalized Medicine

Niels Vande Casteele

Publication May 14, 2019
Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Brian Feagan, Niels Vande Casteele, Vipul Jairath

Publication May 14, 2019
Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn’s Disease and Ulcerative Colitis

Brian Feagan, Christopher Ma, Vipul Jairath

Publication May 14, 2019
Assessment of Crohn’s Disease-Associated Small Bowel Strictures and Fibrosis on Cross-Sectional Imaging: A Systematic Review

Brian Feagan, Christopher Ma, Vipul Jairath